Delivery Order SPE2DB20D3101-SPE2DB24FQTU7
- Not listed
- This federal contract award, valued at $1,867.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for NEXLIZET 180-10 MG TABLET UU 30S, with an ultimate completion date of October 29, 2024. The contract is a firm fixed-price agreement, without any set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,473.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,707.72 firm fixed-price delivery order is for the supply of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,135.03, is for the delivery of NEXLIZET 180-10 MG TABLET medical supplies. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,768.56 with a firm fixed price. It covers the supply of NEXLIZET 180-10 MG TABLET for the DLA, with an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of medical products, specifically NEXLIZET 180-10 MG TABLET in quantities of 30's, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,473.33 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- This federal contract award with a ceiling value of $7,482.35 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of August 14, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no set-aside...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a ceiling value of $2,586.66 for the provision of NEXLETOL 180 MG TABLET to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price agreement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,402.40 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.09 delivery order contract is for the provision of NEXLETOL 180 MG TABLET UU 30S. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a vehicle for supplying a comprehensive range of...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQTU7Delivery Order
This federal contract award, valued at $14,093.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the purchase of NEXLIZET 180-10 MG TABLET in quantities of 30s. This award does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 10/30/23 |